Philips Partners with LeQuest to Provide Online Interactive Training in Ultrasound

PhilipsRoyal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and LeQuest, a leading provider of online interactive simulation-based training for the use of medical devices [1], today announced a partnership to provide online interactive training for the Philips Ultrasound Affiniti system. As a result, medical staff can train individually at their own convenience without the need for equipment, avoiding the resulting loss of operational time on the system, as well as supporting faster onboarding and increasing confidence through practice with realistic simulation scenarios. Healthcare providers benefit from improved workflow, operational efficiencies and better-trained staff.

The Affiniti system offers healthcare professionals a powerful combination of performance and workflow for quick and efficient diagnosis with low operating cost, providing exceptional image quality across applications such as radiology, obstetrics & gynecology, and cardiology. By providing a flexible training solution to healthcare providers, the partnership supports them to achieve key parts of the quadruple aim: an improved experience for staff and patients, better health outcomes and a lower cost of care.

"Partnering with LeQuest enables us to further expand our offering of solutions that aid in optimizing the healthcare ecosystem," said Bich Le, Senior Vice President and General Manager Ultrasound at Philips. "As the role of ultrasound continues to expand, new capabilities, such as remote clinical collaboration and virtual training, have been particularly valuable during the COVID-19 pandemic, enabling providers to reduce in-person contact and reduce infection risk."

"At LeQuest our goal is to improve the quality of care by unlocking the potential of both medical technology as well as the competence of medical staff to use devices to the limit of their possibilities," said Hicham Shatou, founder and CEO of LeQuest. "Our partnership with Philips is an important step on our path to achieving that ambition, extending the global reach of our capabilities and providing Philips ultrasound users with a hands-on experience of its Affiniti system in a virtual environment."

With the LeQuest training modules, users can master the system in an effective way, gain confidence by practicing with realistic simulation scenarios and learn and practice anytime, anywhere. Training modules are available for all models of the Affiniti system (Affiniti 30, 50, 70) with specific versions for each clinical segment (general imaging, obstetrics/gynecology, and cardiology). The LeQuest training modules for the Philips Ultrasound Affiniti system are currently available in LATAM, France, Benelux and Nordics and more countries will follow soon. For more information visit www.lequest.com/en/philips-affiniti.

The partnership with LeQuest adds to Philips' strong portfolio of Clinical Education Services in ultrasound. Helping to combat the COVID-19 pandemic, the company is also providing detailed, practical guidance to support clinicians using its ultrasound systems and software for patients affected by COVID-19. Through its Reacts collaborative platform, Philips is expanding its remote clinical collaboration and virtual training offerings across its portfolio.

About Royal Philips

Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people's health and enabling better outcomes across the health continuum from healthy living and prevention, to diagnosis, treatment and home care. Philips leverages advanced technology and deep clinical and consumer insights to deliver integrated solutions. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, image-guided therapy, patient monitoring and health informatics, as well as in consumer health and home care. Philips generated 2019 sales of EUR 19.5 billion and employs approximately 81,000 employees with sales and services in more than 100 countries.

About LeQuest

LeQuest, founded in 2011 is a leading technology company focused on improving the quality of care by unlocking the potential of both medical technology as well as the competence of medical staff to use devices to the limit of their possibilities. We are developing online interactive simulation-based e- training for the use of medical devices. The LeQuest e-trainings accelerate the implementation of new medical equipment, close the consumption gap, and make users quickly gain confidence, knowledge and competence within a safe environment including certifying and re-certifying of the medical staff. LeQuest is a fast growing company. LeQuest was recently recognized as one of the 250 fastest-growing companies in the Netherlands for 2020.

1. Since 2017, Philips has owned a minority interest in LeQuest through its Philips Health Technology Venture Fund. For more information, please visit www.ventures.philips.com.

Most Popular Now

AI Tool Offers Deep Insight into the Imm…

Researchers explore the human immune system by looking at the active components, namely the various genes and cells involved. But there is a broad range of these, and observations necessarily...

Do Fitness Apps do More Harm than Good?

A study published in the British Journal of Health Psychology reveals the negative behavioral and psychological consequences of commercial fitness apps reported by users on social media. These impacts may...

AI Tool Beats Humans at Detecting Parasi…

Scientists at ARUP Laboratories have developed an artificial intelligence (AI) tool that detects intestinal parasites in stool samples more quickly and accurately than traditional methods, potentially transforming how labs diagnose...

Making Cancer Vaccines More Personal

In a new study, University of Arizona researchers created a model for cutaneous squamous cell carcinoma, a type of skin cancer, and identified two mutated tumor proteins, or neoantigens, that...

A New AI Model Improves the Prediction o…

Breast cancer is the most commonly diagnosed form of cancer in the world among women, with more than 2.3 million cases a year, and continues to be one of the...

AI System Finds Crucial Clues for Diagno…

Doctors often must make critical decisions in minutes, relying on incomplete information. While electronic health records contain vast amounts of patient data, much of it remains difficult to interpret quickly...

AI, Health, and Health Care Today and To…

Artificial intelligence (AI) carries promise and uncertainty for clinicians, patients, and health systems. This JAMA Summit Report presents expert perspectives on the opportunities, risks, and challenges of AI in health...

AI can Better Predict Future Risk for He…

A landmark study led by University' experts has shown that artificial intelligence can better predict how doctors should treat patients following a heart attack. The study, conducted by an international...

Improved Cough-Detection Tech can Help w…

Researchers have improved the ability of wearable health devices to accurately detect when a patient is coughing, making it easier to monitor chronic health conditions and predict health risks such...

Multimodal AI Poised to Revolutionize Ca…

Although artificial intelligence (AI) has already shown promise in cardiovascular medicine, most existing tools analyze only one type of data - such as electrocardiograms or cardiac images - limiting their...

New AI Tool Makes Medical Imaging Proces…

When doctors analyze a medical scan of an organ or area in the body, each part of the image has to be assigned an anatomical label. If the brain is...